Oral-Contraceptive Use and the Risk of Breast Cancer

New England Journal of Medicine

Volumn 315, Issue 7, 1986, Pages 405-411

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN; ETHINYLESTRADIOL; ETYNODIOL DIACETATE; GESTAGEN; MESTRANOL; NORETHISTERONE; NORETHISTERONE ACETATE; NORETYNODREL; NORGESTREL; ORAL CONTRACEPTIVE AGENT; PROGESTERONE;

ADVERSE DRUG REACTION; BREAST; BREAST CANCER; CASE CONTROL STUDY; CHEMICAL CARCINOGENESIS; CONTROLLED STUDY; DRUG MIXTURE; DRUG THERAPY; HUMAN; MAJOR CLINICAL STUDY; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RISK; THERAPY; UNITED STATES;

ADULT; BREAST NEOPLASMS; CONTRACEPTIVES, ORAL; CONTRACEPTIVES, ORAL, COMBINED; CONTRACEPTIVES, ORAL, HORMONAL; ESTRADIOL CONGENERS; FEMALE; HUMANS; MIDDLE AGED; PARITY; PROGESTERONE CONGENERS; RISK; UNITED STATES;

EID: 0022481337     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJM198608143150701     Document Type: Article

References (29)

1. Henderson BE, Powell D, Rosario I, et al. An epidemiologic study of breast cancer. JNCI 1974; 53: 609–14.
2. Sartwell PE, Arthes FG, Tonascia JA. Exogenous hormones, reproductive history, and breast cancer. JNCI 1977; 59: 1589–92.
3. Kelsey JL, Holford TR, White C, Mayer ES, Kitty SE, Acheson RM. Oral contraceptives and breast disease: an epidemiological study. Am J Epidemiol 1978; 107: 236–44.
4. Brinton LA, Williams RR, Hoover RN, Stegens NL, Feinleib M, Fraumeni JF Jr. Breast cancer risk factors among screening program participants. JNCI 1979; 62: 37–44.
5. Ravnihar B, Seigel DG, Lindtner J. An epidemiologic study of breast cancer and benign breast neoplasias in relation to the oral contraceptive and estrogen use. Eur J Cancer 1979; 15: 395–405.
6. Vessey MP, Doll R, Jones K, McPherson K, Yeates D. An epidemiological study of oral contraceptives and breast cancer. Br Med J 1979; 1: 1757–60.
7. Paffenbarger RS Jr, Kampert JB, Chang H-G. Characteristics that predict risk of breast cancer before and after the menopause. Am J Epidemiol 1980; 112: 258–68.
8. Vessey MP, McPherson K, Doll R. Breast cancer and oral contraceptives: findings in Oxford-Family Planning Association study. Br Med J 1981; 282: 2093–4.
9. Royal College of General Practitioners. Breast cancer and oral contraceptives: findings in Royal College of General Practitioners' study. Br Med J 1981; 282: 2089–93.
10. Harris NV, Weiss NS, Francis AM, Polissar L. Breast cancer in relation to patterns of oral contraceptive use. Am J Epidemiol 1982; 116: 643–51.
11. Vessey M, Baron J, Doll R, McPherson K, Yeates D. Oral contraceptives and breast cancer: final report of an epidemiological study. Br J Cancer 1983; 47: 455–62.
12. Long-term oral contraceptive use and the risk of breast cancer: the Centers for Disease Control Cancer and Steroid Hormone Study. JAMA 1983; 249: 1591–5.
13. Rosenberg L, Miller DR, Kaufman DW, et al. Breast cancer and oral contraceptive use. Am J Epidemiol 1984; 119: 167–76.
14. Black MM, Kwon CS, Leis HP Jr, Barclay THC. Family history and oral contraceptives: unique relationships in breast cancer patients. Cancer 1980; 46: 2747–51.
15. Pike MC, Henderson BE, Casagrande JT, Rosario I, Gray GE. Oral contraceptive use and early abortion as risk factors for breast cancers in young women. Br J Cancer 1981; 43: 72–6.
16. Janerich DT, Polednak AP, Glebatis DM, Lawrence CE. Breast cancer and oral contraceptive use: a case–control study. J Chronic Dis 1983; 36: 639–46.
17. Pike MC, Henderson BE, Krailo MD, Duke A, Roy S. Breast cancer in young women and use of oral contraceptives: possible modifying effect of formulation and age at use. Lancet 1983; 2: 926–9.
18. Stadel BV, Rubin GL, Webster LA, Schlesselman JJ, Wingo P. Oral contraceptives and breast cancer in young women. Lancet 1985; 2: 970–3.
19. Waksberg J. Sampling methods for random digit dialing. J Am Stat Assoc 1978: 73: 40–6.
20. Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. JNCI 1959; 22: 719–48.
21. Miettinen OS. Estimability and estimation in case-referent studies. Am J Epidemiol 1976; 103: 226–35.
22. Schlesselman JJ. Case–control studies: design, conduct, analysis. New York: Oxford University Press; 1982:227–69.
23. Hartge P, Brinton LA, Rosenthal JF, Cahill JI, Hoover RN, Waksberg J. Random digit dialing in selecting a population-based control group. Am J Epidemiol 1984; 120: 825–33.
24. Thomas LB, Ackerman LV, McDivitt RW, Hanson TAS, Hankey BF, Prorok PC. Report of NCI ad hoc Pathology Working Group to review gross and microscopic findings of breast cancer cases in the HIP study (Health Insurance Plan of Greater New York). JNCI 1977; 59: 495–541.
25. Coulter A, Vessey M, McPherson K, Crossley B. The ability of women to recall their oral contraceptive histories. Contraception 1986; 33: 127–37.
26. Kelsey JL. A review of the epidemiology of human breast cancer. Epidemiol Rev 1979; 1: 74–109.
27. McPherson K, Neil A, Vessey MP, Doll R. Oral contraceptives and breast cancer. Lancet 1983; 2: 1414–5.
28. Vessey MP, McPherson K, Yeates D, Doll R. Oral contraceptive use and abortion before first term pregnancy in relation to breast cancer risk. Br J Cancer 1982; 45: 327–31.
29. Another look at the pill and breast cancer. Lancet 1985; 2: 985–7.